Drink available in M&S and Waitrose could reduce dementia risk
According to researchers at the University of Exeter, the drink may 'improve brain function in older adults by hijacking ...
Alzheimer's Research UK1h
Walk For A Cure is back for 2025 – will you be taking part?
Walk For A Cure is back for 2025 and this year, Alzheimer’s Research UK will be hosting walks at eight exciting locations across the UK. In 2024, we were proud to have 3,386 participants join our ...
WNYT NewsChannel 131h
First on 13: Glens Falls firefighter with early onset Alzheimer’s to get full retirement
The long-time Glens Falls city firefighter, who was forced to retire early because of early onset Alzheimer's disease, will ...
Two telltale signs of dementia that could appear up to 11 years before symptoms – are you at risk?
TWO telltale signs of dementia that have nothing to do with memory could appear up to 11 years before typical symptoms, ...
BioSpace1h
As US Sales of Leqembi Lag, Eisai Eyes SubQ Approvals
The FDA last month accepted the application for subcutaneous Leqembi for maintenance dosing, with a target action date of ...
Onefootball2h
FA Cup heads to St James’ Park | OneFootball
More than 125 guests had the chance to post with the trophies at St James’ Park ahead of the weekend’s FA Cup double header ...
STAT2h
Lilly expands GLP-1 research to hypertension, neuro conditions
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
alzheimersnewstoday2h
Leqembi IV monthly maintenance dosing approved by FDA
The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.
manilatimes3h
'The convergence between of AI and the Biology' LG Creates "Next-Generation Protein Structure Prediction AI" for Drug Discovery
On the 5th, LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu, ...